CGT Global Blog

CGT Global News

Stay ahead in the dynamic world of Accelerating Cell and Gene Therapy with the CGT Global blog and news page. Explore insightful articles, industry updates, product updates, and expert analysis on all things CGT Global. Stay informed, inspired, and connected with CGT Global – your go-to source for cutting-edge insights in the ever-evolving realm of research, clinical projects and healthcare.

WHAT THE FOUNDATION IS DOING IN OUR COMMUNITY

The StemExpress Foundation is supporting the Leukemia and Lymphoma Society at the Light the Night Walk, November fourth in Sacramento, CA. LLS is an incredible organization which provides hope and resources to people living with blood cancer across the United States, and supports research to end Leukemia and Lymphoma. Each Fall LLS holds the Light the Night Walk where those affected by Leukemia and Lymphoma come together after dark and take lanterns to the streets to spread awareness and show solidarity with…

Read More

Survival and Proliferation of Human NK Cells in Humanized Mice

Natural killer (NK) cells play a critical role in the innate immune system and represent the first line of defense against pathogens and tumor cells. Involved in immune surveillance, NK cells patrol the body looking for infected or cancerous cells. While other immune cells recognize the presence of antibodies on the MHC receptor of infected cells before a response is initiated, NK cells have the ability to respond to stressed cells in the absence of the MHC receptor, allowing a much faster…

Read More

Potential of CRISPR-Cas9-based Technology to Treat Congenital Amegakaryocytic Thrombocytopenia (CAMT)

A single mutation in a gene can lead to rare inherited diseases, such as cystic fibrosis, Tay-Sachs, and sickle-cell anemia, and are often difficult to treat and, for most, have no cure. However, with the current advances in CRISPR-Cas9 genome engineering technology, it may be possible to introduce new immunotherapies to treat these and other inherited diseases. One such disease, congenital amegakaryocytic thrombocytopenia (CAMT), is a rare inherited recessive disorder that occurs when there is a loss-of-function mutation in the MPL gene,…

Read More

CGT Global Folsom Celebrates One Year Anniversary

It’s been one year since StemExpress moved our laboratory headquarters from Placerville to Folsom, CA. Our new state-of-the-art facility has enabled us to increase production and meet the growing needs of our clients. We thank our dedicated staff, the community of Folsom, and our clients for making the past year a successful one.

Read More

Directed differentiation of human bone marrow MSCs to functional Schwann cells

The peripheral nervous system (PNS) comprises many complex cell types that work together to transmit electrical signals from the body’s sensory receptors to the central nervous system (CNS) and vice versa. Peripheral nerve cells relay the electrical signals through the long, thin part of the cell called an axon. Schwann cells create nodes of myelin sheath around the axon called nodes of Ranvier. Between each node is a break essential for increasing the speed of which the electrical signal travels between distant…

Read More

Treating the side effects of chemotherapy

The human body has many lines of defense against infection, keeping us healthy and free of disease. One immediate line of defense is the innate immune system, which is comprised of white blood cells that are ready to fight against bacterial or fungal infection at birth. One of the most numerous and important cells of the innate immune system is phagocytic granulocytes or neutrophils. These cells spend most of their lives circulating in the peripheral blood, but once stimulated by a sequence…

Read More

How CAR-T cell therapy works

On August 30, 2017, the FDA approved the first US CAR-T cell therapy for the treatment of ALL patients. According to FDA Commissioner Dr. Scott Gottlieb, “We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer.” Check out this brief video about how CAR-T cell therapy works. At StemExpress we offer human blood products such as whole blood and Leukopaks as well as peripheral blood CD3+, CD4+, and CD8+ T cells. Purified primary CD3+, CD4+, and…

Read More

Make finding the right human biospecimen easy!

Remove the waiting and the endless paperwork that comes with collecting human biospecimens. With StemExpress’ robust donor pool, we make finding the right donor for your research a simple and straightforward process. StemExpress has partnered with iSpecimen Marketplace to enhance that connection via a straightforward online resource. Through this partnership, StemExpress enhances its capabilities to reach scientists that require a diverse selection of human samples ranging from frozen tumors to blood samples. StemExpress and iSpecimen Marketplace are working together to bring you…

Read More

CGT Global in The Sacramento Bee!

How can a single donation of blood for research impact the research community? With the partnership between StemExpress and researchers around the world, one sample can do a lot! “One patient could help a disease study in multiple places versus just being limited to one researcher at one university,” according to Dr. Michael Chez, a pediatric neurologist with Sutter Medical Center. “If you have multiple people doing the work, it just amplifies how quickly things get done and the statistical power of…

Read More

A New Approach to Treating Myelodysplastic Syndrome

Myelodysplastic syndrome (MDS) is a group of bone marrow disorders where the bone marrow is incapable of producing healthy mature blood cells. Through a process called hematopoiesis, blood stem cells or hematopoietic stem and progenitor cells (HSPC) within the bone marrow give rise to blood cells, such as white blood cells, platelets, and red blood cells. In an individual with MDS the HSPCs fail to mature and either die in the bone marrow or soon after they enter the bloodstream. The lack…

Read More

Integration of Large Transgenes into the Genome of Hematopoietic Primary Cells

RNA-guided CRISPR-Cas9 nuclease is a genome-editing tool that allows researchers to edit parts of the genome by removing, adding, or altering sections of the DNA sequence. CRISPR-Cas9 targets double-stranded DNA using single guided RNA (sgRNA) that shepherds the nuclease to the target DNA sequence. Once at the target, CRISPR-Cas9 creates a double-stranded DNA break. Consequently, the hosts own DNA repair mechanisms, such as non-homologous end-joining (NHEJ) or homology-directed repair (HDR), repairs the break. To alter or correct a dysfunctional gene CRISPR-Cas9 nuclease…

Read More

Important Oversight on Human Germline Genome Editing

In light of the recent article published in Nature, human germline genome editing in the US has taken a front and center stage in the ethical principles and scientific boundaries of modern science. Researchers at the Oregon Health and Science University (OHSU) in Portland, led by reproductive biologist Shoukhrat Mitalipov, corrected a gene mutation responsible for the thickening of the heart muscle in viable human embryos using CRISPR-Cas9 gene editing. Targeting a dominant mutation that leads to heart failure, the researchers obtained…

Read More